Page 219 - 2022_02-Haematologica-web

Letters to the Editor
and Huntsman Cancer Institute, University of Utah Health Sciences Center, University of Utah, Salt Lake City, UT; 4Division of Microbiology & Immunology, Department of Pathology, University of Utah, Salt Lake City, UT; 5Department of Pathology, University of Utah, Salt Lake City, UT and the George E. Wahlen VAMC Department of Medicine and George E. Wahlen VAMC GRECC, Salt Lake City, UT and 6Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Correspondence:
PAUL F. BRAY- Paul.bray@hsc.utah.edu doi:10.3324/haematol.2021.279864 Received: August 24, 2021
Accepted: October 28, 2021.
Pre-published: November 11, 2021. Disclosures: no conflicts of interest to disclose.
Contributions: SB, SJ, ET, BK, YK performed research; PL, IR performed RNA-Seq analysis; SB, PB wrote the manuscript; RO, VP, MR, IR, PF provided scientific expertise.
Funding: this study was supported by grants from the National Institutes of Health National Heart, Lung and Blood Institute (HL116713, HL142804, HL145237, and HL130541), the National Institute of Allergy, Immunology and Infectious Diseases (AI143567), and the Division of Hematology and Hematologic Malignancies at the University of Utah. This work was also sup- ported by Merit Review Award Number I01 CX001696 from the United States (U.S.) Department of Veterans Affairs Clinical Sciences R&D (CSRD). This material is the result of work sup- ported with resources at the George E. Wahlen VA Medical Center, Salt Lake City, Utah. The contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government. The authors thank the University of Utah Flow Cytometry Facility in addition to the National Cancer Institute through Award Number 5P30CA042014-24.
References
1. Cunin P, Nigrovic PA. Megakaryocytes as immune cells. J Leukoc Biol. 2019;105(6):1111-1121.
2. Borden EC, Sen GC, Uze G, et al. Interferons at age 50: past, cur- rent and future impact on biomedicine. Nat Rev Drug Discov. 2007;6(12):975-990.
3. Negrotto S, De Giusti CJ, Lapponi MJ, et al. Expression and func- tionality of type I interferon receptor in the megakaryocytic line- age. J Thromb Haemost. 2011;9(12):2477-2485.
4. Yamane A, Nakamura T, Suzuki H, Ito M, Ohnishi Y, Ikeda Y, Miyakawa Y. Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes. Blood. 2008;112(3): 542-550.
5. Ganser A, Carlo-Stella C, Greher J, Volkers B, Hoelzer D. Effect of recombinant interferons alpha and gamma on human bone mar- row-derived megakaryocytic progenitor cells. Blood. 1987;70(4): 1173-1179.
6. Mazur EM, Richtsmeier WJ, South K. Alpha-interferon: differen- tial suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells. J Interferon Res. 1986;6(3):199-206.
7. Wadenvik H, Kutti J, Ridell B, et al. The effect of alpha-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia. Blood. 1991;77(10):2103-2108.
8. Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the den- dritic- and myeloid-cell-specific HIV-1 restriction factor counter- acted by Vpx. Nature. 2011;474(7353):654-657.
9. Coggins SA, Mahboubi B, Schinazi RF, Kim B. SAMHD1 functions and human diseases. Viruses. 2020;12(4):382.
10. Berger A, Sommer AF, Zwarg J, et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are high- ly susceptible to HIV-1 infection. PLoS Pathog. 2011;7(12): e1002425.
11. Jin C, Peng X, Liu F, et al. Interferon-induced sterile alpha motif and histidine/aspartic acid domain-containing protein 1 expres- sion in astrocytes and microglia is mediated by microRNA-181a. AIDS. 2016;30(13):2053-2064.
12. St Gelais C, de Silva S, Amie SM, et al. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons. Retrovirology. 2012;9:105.
13. Edelstein LC, Simon LM, Montoya RT, et al. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med. 2013;19(12):1609-1616.
14. Bhatlekar S, Basak I, Edelstein LC, et al. Anti-apoptotic BCL2L2 increases megakaryocyte proplatelet formation in cultures of human cord blood. Haematologica. 2019;104(10):2075-2083.
15. Josefsson EC, James C, Henley KJ, et al. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. J Exp Med. 2011;208(10):2017- 2031.
haematologica | 2022; 107(2)
561